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Abstract
Background: To provide evidence synthesis for faster-paced healthcare decision-making, rapid reviews have emerged as
a streamlined alternative to standard systematic reviews. In 2012, the Veterans Affairs Evidence-based Synthesis Program
(VA ESP) added rapid reviews to support Veterans Health Administration (VHA) operational partners’ more urgent
decision-making needs. VHA operational partners play a substantial role in dissemination of ESP rapid reviews through a
variety of routes, including posting on the VA ESP’s public website (http://www.hsrd.research.va.gov/publications/esp/).
As demand for rapid reviews rises, much progress has been made in characterizing methods and practices. However,
evidence synthesis organizations still seek to better understand how and when rapid reviews are being used.
Methods: The VA ESP administered an online survey to rapid review operational partners. The survey assessed the
nature of decision-making needs, overall perception of review content, resulting actions, and implementation
timeframe. We use descriptive statistics and narrative methods to summarize findings.
Results: Between October 2011 and April 2015, we completed 12 rapid reviews for 35 operational partners.
Operational partners were primarily non-academic subject matter experts with VA operations’ decision-making
authority. The most common topic categories reviewed were policy or system (50 %) or process of care (42 %)
initiatives. Median report completion time was 14.5 weeks. Survey response rate was 46 %, with at least one
operational partner responding for 92 % of reports. Reviews served multiple purposes including policy directive
or regulation (72 %), supporting program development and evaluation (55 %), identifying future research needs
(45 %), and determining implementation strategy (45 %). Overall, operational partners’ perception of report content
was positive. A majority of rapid reviews were used immediately and informed actions ranking high on the Institute
of Medicine’s Degrees of Impact framework: 45.4 % effected change, 18.2 % inspired action, 18.2 % informed the
field, 9.1 % received recognition, and 9.1 % spread a message.
Conclusions: VA ESP rapid reviews have increased the VHA’s uptake of evidence to inform time-sensitive system-level
decision-making. Key areas of interest for future evaluation include assessing user perception of our streamlined
methods and the quality of our efforts to inform users of these methods, as well as comparing the usability and
impact of our rapid and standard systematic reviews.
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Background
To meet time-sensitive demands for quality evidence,
rapid reviews have emerged as a streamlined alternative
to standard systematic reviews [1–7]. Rapid reviews are
used by a variety of health organizations such as Kaiser
Permanente, Blue Cross Blue Shield Association, and
University of Pennsylvania Health System, and the de-
mand for them only continues to increase [1, 3, 4, 8].
Rapid review products use various approaches to abbre-
viate the systematic review process. Overall, the two main
sources of variation are timeframe (days to months) and
extent of synthesis (none to both qualitative and quantita-
tive). Hartling et al. [4] grouped rapid review products into
the following four categories based on the extent of syn-
thesis: (1) “inventories” provide a listing of the available
evidence, within 3 days to 6 months; (2) “rapid responses”
present the best available evidence with no formal synthe-
sis, within 5 days to 3 months, and often rely on secondary
sources; (3) “rapid reviews” synthesize the quality of and
findings from the evidence, generally within 2 to 4 months;
and (4) “automated approaches” generate meta-analyses in
response to user-defined queries.
Other common methods of streamlining the systematic
review process include limiting literature searches, extent
of data abstraction and quality appraisal, and the use of
dual independent reviewing [9]. Although rapid reviews
carry the promise of increasing the uptake of evidence in
healthcare decision-making where the alternative is no
evidence at all [1, 2, 5, 10], uncertainty remains about their
potential trade-offs. Concern has been raised that stream-
lining may compromise the quality of the work and
increase the risk of missing evidence or errors in the syn-
thesis, ultimately decreasing utility to end users [3, 4].
Interviews with rapid review producers identified the
“continuous intimate relationship with a specific end
user” and the nature of the decision as key drivers of
rapid review approaches [4]. Rapid reviews also usually
require reaching a consensus quickly, which promotes
involving stakeholders from different backgrounds early
in the process and invites closer attention throughout
the revisions [3]. While much progress has been made
over the past several years in characterizing rapid review
methods and current practices [2, 4–6], less is known
about the users of rapid reviews, their knowledge and
acceptance of the streamlined methods used to produce
rapid reviews, and the impact rapid reviews are having
on health system decision-making [11].
To gain insight into users’ acceptance of methods used
to streamline the systematic review process, an Agency for
Healthcare Research and Quality (AHRQ) Evidence-based
Practice Center (EPC) Method Workgroup conducted
qualitative interviews of eight frequent and known users
(“Key Informants”) of EPC standard systematic reviews
[12]. Key Informants evaluated three sample rapid
products on venous thromboembolism and gave their im-
pressions on streamlining approaches and how they might
use such products. In exchange for shorter review time-
lines, the majority of Key Informants were willing to have
shortcuts made in the literature search (such as limiting
databases, journals, years) and in the abstract and full-text
review process (such as using a single reviewer) rather
than independent review by two reviewers. However, Key
Informants also noted that as potential users may not
be aware of the potential ramifications of streamlining
standard systematic review methods, rapid review pro-
ducers have a responsibility to help educate users about
the process. Finally, Key Informants identified credibility
of the review producer and strength of evidence assess-
ments as critical components of a rapid review. Compared
to the eight Key Informants interviewed, however, less-
frequent users of reviews or varied audiences may have
different perspectives.
Previous evaluations of the impact of rapid reviews
have largely focused on health technology topics used to
inform Canadian provincial healthcare system coverage
and acquisition decisions [13–15]. These evaluations
found that rapid health technology assessments (HTAs)
have consistently influenced policy decisions, including
use as reference material and incorporation of the as-
sessment’s recommendations and conclusions [13, 14].
Similarly, the University of Pennsylvania Health System’s
Center for Evidence-based Practice reported that the
majority of their rapid technology reviews actually in-
formed users’ final clinical practice, policy, purchasing,
and formulary decisions [8]. Additionally, in Quebec,
the budget impact of rapid HTAs developed on-site in
collaboration with end users was estimated at approxi-
mately $3 million in savings per year [15]. Although
these rapid HTAs were seen as useful, some authors
acknowledged that they were typically considered only
as interim products that should be followed up with full
assessments. This is because the short timeframes in-
creased the chance of providing inappropriate advice
and typically restricted the scopes to only addressing
questions of efficacy or effectiveness [14].
These studies provide preliminary information on the
use and influence of rapid HTAs in a few specific set-
tings. As healthcare decision-makers are increasingly de-
manding accelerated forms of evidence synthesis, rapid
reviews are meeting an important need within health
systems. It is important, however, to better understand
when and in what capacity rapid reviews are used, as
well as the mechanisms that help or hinder their imple-
mentation from the user’s perspective for a broader
range of topics and settings [11].
The Veterans Affairs’ Evidence-based Synthesis Program
(VA ESP) was established in 2007 to provide the Veterans
Health Administration (VHA) with timely and accurate
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evidence synthesis on important topics to meet their
healthcare decision-making needs and to improve
Veterans’ health and healthcare [16]. The VA Quality
Enhancement Research Initiative (QUERI) provides
funding for four ESP Centers, and each Center has an
active university affiliation with close ties to the AHRQ
Evidence-based Practice Center Program. The Centers
are located at the Durham and West Los Angeles VA
Medical Centers, the Minneapolis VA Health Care
System, and the VA Portland Health Care System. The
ESP Coordinating Center (ESP CC), also located in
Portland, oversees national ESP program operations,
program development and evaluation, and dissemin-
ation efforts. Each Center is led by a VA clinician inves-
tigator and staffed with 2–3 FTE research assistant/
associates. The Centers rely heavily on fellows and resi-
dents to round out review teams, and each produces 3
standard systematic reviews annually.
In 2012, in response to VHA operational partner feed-
back, the VA ESP added rapid reviews to support the
VHA’s more urgent decision-making needs [17]. The
ESP CC increased capacity to provide this product and
added a dedicated research staff with extensive system-
atic review expertise. The rapid review team is led by a
VA clinician researcher (.10 FTE) and consists of 1.6
FTE research associates, .50 FTE librarian, and .50 FTE
research assistant and utilizes the support of existing
ESP CC infrastructure including a full-time Associate
Director charged with program management and an edi-
torial coordinator. The ESP CC conducts 3 to 5 rapid re-
views each fiscal year. Consequently, rapid reviews are
reserved for topics which (1) are identified as top prior-
ity by senior management, (2) would potentially have
important consequences if delayed, and (3) have a mech-
anism in place that will allow for rapid implementation
of findings. VA ESP rapid review products are completed
within 4 months, include primarily qualitative syntheses
and conclusions that rely on internal validity and
strength of evidence assessments, and are subjected to
external peer review, which best resemble the “rapid re-
view” type of products from the taxonomy described
above [4]. Our primary means of gaining efficiency is by
tailoring the scope to focus on parameters that would
drive the operational partners’ decision-making (for ex-
ample, health outcomes vs intermediate outcomes). De-
pending on the volume of evidence and time allowed,
other steps may be taken to abbreviate the review process,
including substituting the second reviewer verification of
study selection, data abstraction, quality assessment, and
strength of evidence ratings for dual independent review.
The VA ESP rapid reviews are led by experienced system-
atic reviewers who draw on core systematic review values
of focusing on the highest-quality evidence, minimizing
bias, and maximizing transparency to make decisions
about how to abbreviate processes. ESP rapid reviews have
primarily addressed process of care, access topics, and sys-
tems policy initiative needs.
Operational partners play a substantial role in dissemin-
ation of ESP rapid reviews through a variety of routes. All
rapid reviews are posted on the VA ESP’s public program
website (http://www.hsrd.research.va.gov/publications/esp/)
and indexed in PubMed and may be submitted for publi-
cation in peer-reviewed journals where appropriate. The
ESP CC consults with operational partners to develop a
tailored plan for each report, identifying appropriate
strategies that are topic-specific and targeted to optimize
uptake by the health system. Dissemination efforts may
include (1) VA Cyberseminars (i.e., national, online, free,
video-archived presentations of report findings), which are
augmented by policy and clinical work in order to make
the presentations relevant and applicable to clinicians,
administrators, and researchers and (2) presentation of
findings at leadership briefings, program/committee
meetings, or conferences. Operational partners also fre-
quently recommend dissemination strategies and targets
for “Management eBriefs,” an electronic publication to
provide VHA management with a concise summary of
report findings, including implications for VHA policy or
practice.
In early 2015, the VA ESP initiated a quality improve-
ment effort aimed at understanding the utility of the
evidence products and their impact on decision-making
in the VHA. The project involves surveying operational
partners—high-level VHA leadership that request and
use the evidence products—regarding (1) the nature of
their decision-making needs, (2) actions resulting from
the report’s findings, (3) implementation timeframe, and
(4) overall perception of report content. These objectives
were inspired by the VHA’s and QUERI’s goals of rapidly
translating research findings and evidence-based treat-
ments into clinical practice, increasing the impact of VA
research findings through evaluation, and promoting
the VHA as a learning healthcare organization through
innovative implementation science [18]. In this article,
we report on the retrospective survey results for 11
(out of 12) rapid reviews completed between 2011 and
2015. Our survey findings extend knowledge on users’
perspectives of how and when they use rapid reviews to
different types of users, settings, and report topics than
have been previously evaluated.
Methods
The VA ESP CC drafted the initial survey instrument
based on the QUERI Strategic Plan, the VHA Strategic
Plan (“Blueprint for Excellence”), and their linkage to the
goals of the ESP. The ESP CC refined the survey based on
feedback from the Directors of the ESP Centers as well as
VA research and implementation leadership. The final
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survey assessed the following: (1) nature of decision-
making needs, (2) actions resulting from the report’s
findings, (3) implementation timeframe, and (4) overall
perception of report content. The survey comprised
both open- and closed-ended questions, to encourage
respondents to provide in-depth detail regarding the
quality of the review’s content and actions taken as a
result of the report findings (see Additional file 1). We
administered the survey using Survey Monkey (Survey-
Monkey Inc. Palo Alto, CA), an online, cloud-based survey
creation and administration tool. The survey was reviewed
and approved as quality improvement based on VHA
policy [19].
Study participants were operational partners, defined
as leaders of a VHA national program office or business
line who are responsible for national clinical programs
or policies in the deployment of VHA health services.
We surveyed all 35 operational partners who requested
all 12 VA ESP rapid reviews we produced from 2011 to
2015. We recruited operational partners via an email
that included a link to the online survey. In the recruit-
ment email, we notified operational partners that we
would keep their identities confidential. We sent the sur-
veys out in four groups between July and October of
2015. We gave operational partners 4 weeks to respond.
We sent nonrespondents a reminder email at 14 days.
We compared survey respondents and nonrespondents
with respect to their organizational role: (1) Academic
Researchers charged with leading system-wide health/
quality improvement efforts (no VA operation decision-
making authority), (2) non-academic Subject-Matter
Experts (SME) with VA operation decision-making au-
thority, including National Program Offices, Central
Office, and Chief Consultants, or (3) non-academic Health
System Managers with VA operation decision-making au-
thority, such as VISN Directors or Chief Medical Officers.
We imported survey results into Microsoft Excel
(Microsoft Corp, Redmond, WA) and used Stats Direct
Version 2.8.0 (CamCode, UK) for analysis. We conducted
statistical comparisons using χ2 and Fisher’s exact tests.
Narrative methods were used to analyze open-ended re-
sponses. We organized the open-ended responses about
actions resulting from the report based on the Institute of
Medicine’s (IOM) Degrees of Impact—a scale intended to
gauge impact made in health systems [20]. This scale
provides metrics for assessing five levels of impact: (1)
effecting change (e.g., revision of guidelines, legislation
enacted), (2) inspiring action (e.g., legislation intro-
duced, advocacy initiatives), (3) informing the field (e.g.,
subject of meeting or hearing), (4) receiving recognition
(e.g., formal response by stakeholders), and (5) spreading
the message (e.g., published article). For open-ended re-
sponses about how ESP reports compared with other
evidence sources, we categorized them as (1) compares
equally/similar, (2) prefers ESP for VA focus, (3) no
opinion, and (4) other. Open-ended responses were ini-
tially coded by one reviewer and verified by one or two
other reviewers. Disagreements were resolved by con-
sensus. Close-ended responses were evaluated using de-
scriptive statistics. We planned to explore heterogeneity
in operational partners’ perception of content as poten-
tial sources of variability in report impact.
Results
Review characteristics
Between 2011 and 2015, we completed 12 rapid reviews
for 35 operational partners (Table 1). Reviews had on
average three operational partners (range, 1 to 9). The ma-
jority (94 %) of operational partners were non-academic
SMEs and two (6 %) were non-academic Health System
Managers. Overall, the majority of reviews examined
policy or organizational/managerial system topics (50 %),
defined as “a report primarily examining laws or regula-
tions; the organization, financing, or delivery of care,
including settings of care; or healthcare providers,” or
process of care topics (42 %), defined as “a report pri-
marily examining a clinical pathway or a clinical practice
guideline that significantly involves elements of preven-
tion, diagnosis, and/or treatment” [8]. Due to limited and
heterogenous evidence, only two rapid reviews provided
opportunities to perform original meta-analyses of small
numbers of studies (repetitive transcranial magnetic stimu-
lation for treatment-resistant depressions, updates on the
prevalence of and interventions to reduce racial and ethnic
disparities). We have increased our use of strength of evi-
dence assessments over time, for an overall rate of 67 %.
Median time to report completion was 14.5 weeks overall,
increasing from 9 weeks in the first year to 20 weeks in the
fourth year to more regularly incorporate strength of
evidence assessment and peer review processes. Beyond
posting reviews on our public website, additional dis-
semination activities varied across topics and time.
Survey findings
Survey response rate was 46 % (range, 0 to 100 % per
review) (Fig. 1). Eleven out of 12 reviews had at least
one operational partner respond (92 %). Data was com-
pleted and analyzed for all 16 respondents. Nineteen of
35 (54 %) operational partners did not respond to the
survey (Fig. 1). The proportions of Health System
Managers were similar between responders and nonre-
sponders (12.5 vs 0 %; P = .20). Respondents were asked
to select the variety of ways in which they were in-
volved in the review process. Sixty-nine percent pro-
vided input on the scope of the review, 63 % gave
feedback on the draft report, 63 % were briefed on the
report’s findings, and 50 % had periodic contact
throughout the review process.
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Table 2 displays the types of reports, findings, and
what the user perceived as their primary purpose. Res-
pondents indicated that reviews served multiple purpo-
ses—an average of 2.25 purposes per report. The most
common review purposes were the following: policy
directive or regulation (72 %), supporting program de-
velopment and evaluation (55 %), identifying future re-
search needs (45 %), and determining implementation
strategies (45 %).
Perceptions of the content
Overall, operational partners generally perceived the re-
port content as favorable (Table 3). Eighty-one percent
stated that the scope was “about right” whereas 19 % de-
scribed it as “too narrow.” All operational partners
“strongly agreed” or “agreed” with the findings of the re-
port. Over half of the operational partners stated the
ESP reports compared equally to other evidence sources
such as Cochrane or AHRQ systematic reviews; 12.5 %
Initial Recruitment: N = 35
Surveyed all 35 operational partners of all 12 
rapid reviews completed between 2011 and 2015
Responders: N = 16 (46%)
14 (87.5%) non-academic subject matter experts
2 (12.5%) non-academic health system managers 
Non-responders: N = 19 (54%)
19 (100%) non-academic subject matter experts
16 (84%) unknown reason for non-response
3 (16%) retired or left the VA
Final Sample: N =16
Survey data from all 16 responders included in 
analysis
Fig. 1 Survey respondents, non-respondents, and response rates
Table 1 Summary of review topic categories, methodology, timeframe, and dissemination by fiscal year (FY)
Overall (N = 12) FY12 (N = 2) FY13 (N = 5) FY14 (N = 4) FY15 (N = 1)
Median report completion time (in weeks) 14.5 9 15 15 20
Report topic category
Policy or organizational/managerial systema 6 (50 %) 0 4 (80 %) 2 (50 %) 0
Process of careb 5 (42 %) 2 (100 %) 1 (20 %) 1 (25 %) 1 (100 %)
Device 1 (8 %) 0 0 1 (25 %) 0
Methodology
Performance of original meta-analyses 2 (17 %) 0 % 0 % 1 (25 %) 1 (100 %)
Performance of strength of evidence assessments 8 (67 %) 1 (50 %) 3 (60 %) 3 (75 %) 1 (100 %)
Dissemination
Publically available on VA website 12 (100 %) 2 (100 %) 5 (100 %) 4 (100 %) 1 (100 %)
Management eBriefs 3 (25 %) 1 (50 %) 0 % 1 (25 %) 1 (100 %)
Cyberseminars 1 (8 %) 1 (50 %) 0 % 0 % 0 %
Peer-reviewed journal submission in process 3 (25 %) 0 1 (20 %) 1 (25 %) 1 (100 %)
Presentation of findings at leadership briefings,
program/committee meetings, or conferences
5 (42 %) 1 (50 %) 3 (60 %) 0 % 1 (100 %)
aA report primarily examining laws or regulations; the organization, financing, or delivery of care, including settings of care; or healthcare providers [8]
bA report primarily examining a clinical pathway or a clinical practice guideline that significantly involves elements of prevention, diagnosis, and/or treatment [8]
Peterson et al. Systematic Reviews  (2016) 5:132 Page 5 of 12







General findings Link to report
Role of the annual physical
examination in the
asymptomatic adult
0/1 (0 %) No response obtained 6 weeks Comprehensive routine physical
examinations are not recommended




Effect of geriatricians on
outcomes of inpatient and
outpatient Care
2/3 (67 %) Determine implementation strategy;
guideline or directive; support resource
allocation decisions; clinical guidance
12 weeks The impact of geriatrician involvement
on patient function and healthcare
utilization varies across the different







2/9 (22 %) Clinical guidance; identify future
research needs; support program
development and evaluation
activities
16 weeks Inconsistent findings on whether these




Developing a threshold for
small VA hospitals
1/4 (25 %) Guideline or directive; identify future
research needs; determine
implementation strategy
12 weeks A relationship between hospital size and
quality measures was either not found





Effects of small hospital
closure on patient outcomes
1/2 (50 %) Resource allocation decisions 15 weeks Low-strength evidence that hospital
closures leading to increased distance







delay to colonoscopy and
colorectal cancer outcomes
3/5 (60 %) Guideline or directive; clinical
guidance; determine
implementation strategy
16 weeks No evidence to support current policy
requiring follow-up colonoscopy within





Review of reviews on specialty
care topics
1/3 (33 %) Program development and
evaluation activities
4 weeks Provided inventory of main findings from
systematic reviews on the topics of shared
decision-making in palliative care, oncology,
and nephrology; interventions that reduce
hospitalizations/emergency room (ER) visits
for heart failure and chronic obstructive
pulmonary disease (COPD); and
interdisciplinary specialty care
platforms/teams/neighborhood approaches





computer trainings on ethical,
workplace, and security topics



















Table 2 Report characteristics (Continued)
Primary care initial appointment
wait times threshold
1/1 (100 %) Guideline or directive 6 weeks No clear support for broad use of any
specific wait time standard for new
patients in accessing their first primary care
or mental health appointment. Offered potential




Factors that optimize therapy
with repetitive transcranial magnetic
stimulation for treatment-resistant
depressions
1/3 (33 %) Clinical guidance 16 weeks High-frequency rTMS applied to the left
dorsolateral prefrontal cortex is the
best-studied approach and it includes a
FDA-cleared protocol that has been




Quality of care provided by
advanced practice nurses
1/2 (50 %) Inform proposed regulation 24 weeks Low-strength evidence suggesting no
difference in health status, quality or life,
mortality, or hospitalizations favoring either





Updates on the prevalence of
and interventions to reduce racial
and ethnic disparities
2/2 (100 %) Guideline or directive; identify
future research needs; support program
development and evaluation activities;
resource allocation decisions
20 weeks Moderate- and low-strength evidence of
worse morbidity and mortality outcomes
for some racial minority Veterans groups















preferred ESP reports for the VA focus. Regarding the
restrictions on the scope and syntheses, the majority of
respondents did not believe or thought they only pos-
sibly limited the usefulness of the rapid reviews. As only
27 % of respondents would have had access to other evi-
dence sources in the absence of a rapid review, this indi-
cates that the ESP rapid reviews have increased the
VHA’s uptake of evidence for informing time-sensitive
system-level decisions. We also asked operational partners
if the report presented a clear understanding of how find-
ings fit within the VA context (Fig. 2). Twenty-five percent
“strongly agreed” and 69 % “agreed” with the statement.
Only 6 % reported a neutral opinion on this measure.
Resulting actions and implementation
A majority of ESP rapid reviews were used immediately
and informed high-impact health system decisions. The
majority of responders either strongly agreed (25 %) or
agreed (50 %) that the report influenced the VA health-
care delivery system (Fig. 2). Figure 3 illustrates specific
actions that resulted from the report and where these
actions fall on the IOM’s Degrees of Impact scale, as well
as when the report was used by operational partners.
Five reports (45.4 %) yielded the highest level of impact
by supporting or creating a directive on specific clinical
or health systems issue. Another 18.2 % inspired action
such as partnerships and plans to modernize current
practices, 18.2 % informed the field in ways such as
disseminating the evidence review within the field or
helping plan educational trainings or meetings, 9.1 % re-
ceived recognition, and 9.1 % spread a message. These
qualitative perspectives in conjunction with the positive
ratings on the scope, applicability, and usefulness of
rapid reviews suggest that users of rapid reviews are
both satisfied with the rapid product itself and use it to
make decisions. Operational partners’ perceptions of
rapid review content were generally homogeneous and
therefore do not appear related to variability in report
impact.
In addition to the VA ESP rapid review, 100 % of re-
spondents indicated that other factors influenced their
decision-making process. Operational partners reported
an average of 2.75 other factors that influenced the
decision-making process. Figure 4 illustrates the distribu-








0% 20% 40% 60% 80% 100%
Don't know Neither agree/disagree Agree Strongly agree
The report 
influenced the VA 
health care delivery 
system
The report 
presented a clear 
understanding of 
how findings fit 
within VA context
Fig. 2 Operational partner perceptions of ESP report influence and applicability of findings
Table 3 Operational partners' perceptions of report content
Frequency
How would you describe the scope of the report?
About right 81 %
Too narrow 19 %
To what extent do you agree or disagree with the
findings of the report?
Agree 69 %
Strongly agree 31 %
How do the ESP reports you’ve read compare with
other evidence sources?
Compare equally/similar 56 %
Prefer ESP for VA focus 12.5 %
No opinion 19 %
Other (eg, acknowledge benefits of different products) 12.5 %
Do characteristics of RR limit the usefulness of the report?a
No 53 %
Maybe 33 %
No opinion 14 %
Yes 0 %
Without RR, how would you have addressed your
research need?a,b
Clinical/expert opinion 40 %
Nothing–would have had to make decision without
evidence review
20 %
Used other evidence source 27 %
aN = 15 for these measures–missing responses for one report
bRespondents could select multiple options for this item. Here we listed the
most frequent responses.
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include other stakeholders (69 %), other VA offices (69 %),
clinical/expert opinion (69 %), Veterans input (18.75 %),
political pressure (18.75 %), economic pressure (12.5 %),
and other evidence sources (12.5 %).
Discussion
Our survey of VHA leadership has improved our under-
standing of how and when our VA ESP rapid reviews are
being used to inform time-sensitive healthcare decision-
making within the VA healthcare system. Also, these
findings extend knowledge on users’ perspectives of how
and when they use rapid reviews to different types of
users, settings, and report topics than have been previ-
ously evaluated. Overall, operational partner feedback
was positive. During its first 3 years of offering rapid re-
views, the ESP program increased the uptake of evidence
to inform the VHA’s time-sensitive decision-making
needs, particularly on occasions where the alternative
was no review of the evidence at all. The majority of
ESP rapid reviews were used immediately and informed
actions that ranked high on the IOM’s Degrees of Im-
pact framework: 45.4 % effected change, 18.2 % inspired
action, 18.2 % informed the field, 9.1 % received recogni-
tion, and 9.1 % spread a message. This specifically
• Relationship between Time Delay to Colonoscopy and Colorectal 
Cancer Outcomes: “VHA Directive on CRC screening (we omitted any 
mention of timelines as a result of the report)” (used immediately)
• Primary Care Initial Appointment Wait Times Threshold: “The data 
suggested that the time frame that was established [in Policy Directive] was 
probably appropriate at least for the circumstances in the literature.”  (used 
immediately)
• Quality of Care Provided by Advanced Practice Nurses: “Regulation was 
developed for public comment.” (used within 6 months)
• Effectiveness of Primary Care Programs: "The report supported decision 
making to continue to develop the PACT Intensive Management (PIM) 
initiative, including the funding of 5 pilot sites." (used within 6 months)
• Effect of Geriatricians on Outcomes of Inpatient and Outpatient Care: 
“The evidence review revealed that existing evidence did not provide 
evidence of efficacy of this intervention. The review was extremely 
informative and was decisive in its influence on the committee members. The 
policy proposal was withdrawn.”  (used multiple times: immediately; within 6 
months)
Effecting Change
• Developing a Threshold for Small VA Hospitals: “VHA conducted an 18-
month Modernization Study, developed a report...and subsequently 
implemented a plan to modernize the health care delivery, partnerships and 
collaborations, capital infrastructure, and supply chain processes” (used 
immediately)
• Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant 
Depressions: “We will ask our field advisory to recommend general 
guidelines concerning the use of emerging technologies in the field.” (used 
within 3 months)
Inspiring Action
• Effectiveness of Mandatory Computer Trainings on Ethical, 
Workplace, and Security Topics: “This was useful to send broadly out to 
education leaders and organizational leaders…” (used immediately)
• Review of Reviews on Specialty Care Topics: “I was able to use this 
report to expand health services research expertise in shared decision 
making for specialty care and I planned training on shared decision making 
for junior VA researchers.” (used immediately)
Informing the 
Field
• Update on Prevalence of and Interventions to Reduce Racial and 
Ethnic Disparities: '“I used this [report] in an HSR&D disparities research 
portfolio review. [It] indicated the inadequacy of our knowledge on both 




• Effects of Small Hospital Closure on Patient Outcomes: “The report 
supported the analysis of our delivery system and created a basis for 
decision making; It was very helpful to have this objective review to inform 
our work.” (used immediately)
Spreading 
the Message
Fig. 3 ESP reports within the IOM Degrees of Impact scale and time of use
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addressed the VHA’s strategic goal of rapidly translating
research findings and evidence-based treatments into
clinical practice [21]. Although VA rapid review topics
are carefully prioritized based on a clear demonstration
of urgency and presence of a mechanism for implemen-
tation, given the challenges and uncertainty of conduct-
ing rapid reviews, it is reassuring to confirm that they
are being used as intended.
Our findings are consistent with previous evaluations of
the impact of rapid HTAs which all found them to be
valuable products [9]. Timely access to evidence and col-
laboration between researchers and policymakers—which
are both key characteristics of rapid reviews—have fre-
quently been reported as facilitators of implementation of
evidence [4, 22, 23]. Previous research on the impact of
rapid reviews has primarily focused on their use for clin-
ical practice, policy, purchasing, and formulary decisions
primarily in non-US settings [13–15]. It is useful to learn
that the value of rapid reviews extends to a large US
healthcare setting, such as the VA health system, for the
types of process of care, access, and systems policy initia-
tive topics addressed by the ESP rapid reviews.
It is important to note that the implementation of evi-
dence depends not only on the content and purpose of
the evidence but also on the complex environment around
the topic, user, and agency [23]. Operational partners indi-
cated that there were on average 2.75 additional factors
influencing their decisions, including other stakeholders
(69 %), other VA offices (69 %), clinical/expert opinion
(69 %), Veterans input (18.75 %), political pressure
(18.75 %), economic pressure (12.5 %), and other evidence
sources (12.5 %). This suggests that our rapid reviews
served as only one tool from a variety of inputs within a
complex decision-making process. Learning more about
the VHA decision-makers’ processes for weighing the rela-
tive contribution of rapid reviews among these different
inputs, and how that may differ for standard systematic
reviews, may improve our understanding of the conse-
quences of our rapid reviews’ potential limitations.
These initial results have some limitations that we plan
to address in future quality improvement efforts. First,
although our operational partners’ feedback was very posi-
tive overall, this needs to be taken in context with our low
response rate. However, the similarity between nonre-
sponders and responders in their organizational roles does
not clearly suggest any obvious differences in their per-
ceptions of the reviews. It is also possible that our low
response rate may be due in part to our minimal efforts
to remind participants to respond to the survey. For ex-
ample, although we discovered that 16 % of our nonre-
sponders were not reachable because they had retired
or were no longer with the VA, we made no further
attempts to contact them. Further, we only reminded par-









Fig. 4 Factors influencing operational partner decision-making beyond the rapid evidence synthesis
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reminders used in the recent University of Pennsylvania
Health System’s Center for Evidence-based Practice survey
that had a higher response rate (72 %) [8]. We also did
not employ the use of telephone reminders which have
a known association of increased response rates (77 vs
53 %, P < .001) [24]. But the possibility of nonresponse
bias remains, as other unknown differences between
nonresponders and responders could exist.
Second, the retrospective nature of our preliminary
data collection may raise the risk of recall bias for some
of the survey items. As actions resulting from the rapid
reviews are objective and a matter of record, survey
items measuring impact likely have the lowest risk of
recall bias. However, for survey items measuring the
VHA leaderships’ perception of report content, the risk
of recall bias may be greater, particularly for the older
reports. We attempted to reduce this risk by providing
copies of the reports along with the survey; however, it
is ultimately unknown how familiar respondents were
with the reports’ contents. For all future rapid reviews,
we plan to address this issue by routinely surveying
users only 6 months after the review’s completion. Third,
although we made progress in assessing our operational
partners’ acceptance of some of the potentially important
trade-offs of rapid reviews (i.e., restricted scopes and
syntheses), we have not yet addressed their perceptions of
other specific methods to streamline the systematic review
process. Empiric evidence is sparse and mixed about
whether rapid reviews have less-accurate findings than
systematic reviews because they often do not meet all the
accepted methodological standards of standard systematic
reviews [9]. For this reason, further investigation of the
consequences of various methodological shortcuts con-
tinues to be among the top three key areas of interest for
future rapid review research topics [11]. Fourth, our
survey did not specifically assess how well we educated
operational partners about and reported on the specific
methodological alterations we made to gain efficiency and
their potential ramifications. In the general interest of
transparency and reporting guideline adherence, and
because user education was a theme that emerged from
AHRQ’s EPC Program interviews of potential rapid review
users, this also warrants further consideration [12]. Finally,
our findings should be interpreted as preliminary as
our small sample size may have limited the reliability of
our findings. We plan to continue surveying a larger
number of users over the next several years, which will
increase confidence in our findings and allow a more
thorough evaluation of potential sources of variation in
use and impact.
Conclusions
Retrospective survey results preliminarily suggest that VA
ESP rapid reviews have increased the VHA’s uptake of
evidence for time-sensitive healthcare decision-making.
The majority of ESP rapid reviews were used immediately
and informed high-impact VHA decision-making. Key
areas of interest for future evaluation include further
assessment of users’ perceptions of specific methods we
used to streamline the systematic review process and
the quality of our efforts to educate about and report
on such methods. Another important next step is to
compare the usability and impact of VA ESP rapid and
standard systematic reviews in meeting VHA leadership
operational partner needs.
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